
    
      In this study 4 groups have been taken. Two groups of cases including Alcoholic patients and
      acute liver failure which are given G-CSF therapy and two groups of controls given standard
      therapy. Primary end point is to see the mobilization of CD-34 hematopoietic cells and
      survival. Secondary end point is to see the clinical and biochemical improvement in liver
      functions.
    
  